Detalhe da pesquisa
1.
Instrument selection for the ASAS core outcome set for axial spondyloarthritis.
Ann Rheum Dis
; 82(6): 763-772, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680390
2.
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study.
Ann Rheum Dis
; 80(8): 1004-1013, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906853
3.
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Ann Rheum Dis
; 79(11): 1400-1413, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759265
4.
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.
Rheumatology (Oxford)
; 59(3): 568-574, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410469
5.
Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
Rheumatol Int
; 39(1): 121-130, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426237
6.
Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update'.
Ann Rheum Dis
; 2020 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32963048
7.
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Rheumatol Ther
; 11(2): 313-329, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252211
8.
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.
Rheumatol Ther
; 11(3): 487-499, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696034
9.
The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
Hum Mol Genet
; 20(1): 141-54, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940148
10.
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling.
Nat Cell Biol
; 8(8): 834-42, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16862145
11.
Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial.
Rheumatol Ther
; 10(4): 1001-1020, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331992
12.
Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis.
ACR Open Rheumatol
; 5(12): 632-643, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775977
13.
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
Ther Adv Musculoskelet Dis
; 15: 1759720X221149965, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36777695
14.
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
Rheumatol Ther
; 10(5): 1255-1276, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458964
15.
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database.
Adv Ther
; 39(6): 2932-2945, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482248
16.
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo.
Arthritis Res Ther
; 24(1): 40, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139908
17.
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey.
Rheumatol Ther
; 9(3): 823-838, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299259
18.
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis.
RMD Open
; 8(2)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814062
19.
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months.
Arthritis Care Res (Hoboken)
; 74(1): 131-141, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34057820
20.
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial.
RMD Open
; 8(2)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654457